Capecitabine induced inflammation of actinic keratoses

Dermatology Online Journal

Volumn 13, Issue 4, 2007, Pages

  Krathen, M ^a   Treat, J ^a   James, W D ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; FLUOCINOLONE ACETONIDE; FLUOROURACIL; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ACTINIC KERATOSIS; AGED; ANAMNESIS; ARTICLE; BREAST CANCER; CASE REPORT; FEMALE; HUMAN; METASTASIS; PHYSICAL EXAMINATION; PRURITUS; SKIN INFLAMMATION; SKIN IRRITATION; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; INFLAMMATION; KERATOSIS; ULTRAVIOLET RADIATION;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; INFLAMMATION; KERATOSIS; ULTRAVIOLET RAYS;

EID: 36448932684     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. E. B. Lamont and R. L. Schilsky. The oral fluoropyrimidines in cancer chemotherapy. Clin Cancer Res. 1999 Sep;5(9):2289-96.
2. Capecitabine (Xeloda ©) Product Insert. Roche Pharmaceuticals. Nov 2000.
3. W. Fu and C. J. Cockerell. The actinic (solar) keratosis: a 21st-century perspective. Arch Dermatol. 2003 Jan;139(1):66-70.
4. G. M. Higa, R. F. Kovach and J. Abraham. Actinic keratosis and capecitabine therapy. J Oncol Pharm Pract. 2005 Dec;11(4):151-3.
5. K. G. Lewis, M. D. Lewis, L. Robinson-Bostom and T. D. Pan. Inflammation of actinic keratoses during capecitabine therapy. Arch Dermatol. 2004 Mar;140(3):367-8.